Endocrinology manages some of medicine's most chronic, complex conditions — type 1 and type 2 diabetes, thyroid disorders, adrenal conditions, pituitary disease, osteoporosis, and metabolic syndrome. These conditions require longitudinal care, frequent lab monitoring, medication adjustments, and substantial patient education. The administrative demands match the clinical complexity: prior authorizations for continuous glucose monitors (CGMs), insulin pumps, GLP-1 agonists, and other specialty medications have become extraordinarily burdensome. Endocrinologists in busy practices spend hours weekly navigating insurance requirements for treatments that significantly improve patient outcomes but face payer scrutiny. A virtual assistant for endocrinologists systematically manages this administrative burden, allowing practices to serve more patients with complex metabolic conditions. This guide covers what endocrinology practices can delegate and how to build an effective VA support system.
Endocrinology Practice Tasks for VA Delegation
Endocrinology administration spans medication and device authorization, lab coordination, patient education support, and chronic disease management communications.
| Task | Description | VA Level | Rate Range |
|---|---|---|---|
| CGM/Insulin Pump Prior Auth | Submitting PAs for CGM devices, sensors, insulin pumps with clinical documentation | Mid–Senior | $14–$22/hr |
| GLP-1 and Specialty Med Auth | PAs for semaglutide, tirzepatide, SGLT2 inhibitors, specialty insulins | Mid–Senior | $14–$20/hr |
| Lab Coordination | Ordering and tracking HbA1c, thyroid panels, lipids, bone density | Entry–Mid | $10–$14/hr |
| Referral Management | Processing endocrinology referrals, coordinating with PCPs/cardiologists | Mid | $12–$16/hr |
| Patient Communication | Lab result follow-up, medication refill routing, education material delivery | Entry–Mid | $10–$14/hr |
| Device Management | CGM and pump supply reorder coordination, manufacturer support contacts | Entry–Mid | $10–$14/hr |
| Insurance Verification | Benefits verification, specialty pharmacy coverage, specialty tier costs | Mid | $12–$16/hr |
| Insurance Appeals | Appealing denials for CGM, insulin pump, and specialty medications | Senior | $18–$25/hr |
Prior Authorization for Diabetes Technology
CGM prior authorization has become one of endocrinology's most burdensome administrative functions. Continuous glucose monitors — Dexcom G7, Abbott FreeStyle Libre, Medtronic Guardian — require prior authorization from most commercial payers and Medicare Advantage plans, with criteria that typically require documented diabetes diagnosis, HbA1c thresholds, or insulin use. Annual renewals are required, and criteria vary significantly by payer.
An experienced VA manages CGM authorization comprehensively: tracking every patient's CGM auth status, initiating renewals 30–60 days before expiration, submitting new patient authorizations with complete clinical documentation, and following up aggressively on pending auths. For patients denied CGM coverage, they gather the additional documentation needed for appeal — frequency of hypoglycemic episodes, clinical impact of glucose variability, physician letter of medical necessity — and submit appeals with strong supporting evidence.
Similarly, they manage insulin pump prior authorizations: pump therapy criteria submissions, C-peptide documentation when required, and the complex upgrade authorization process when patients need new pump technology.
This systematic device authorization management prevents the gaps in coverage that force patients to go without devices they depend on for glucose control — and eliminates the physician and staff time currently consumed by these complex submissions.
"CGM and pump auths were consuming my clinical coordinator's entire day. My VA handles every authorization — initial, renewal, and appeal. Coverage gaps have essentially gone to zero and my coordinator is back to doing patient care coordination." — Endocrinologist, diabetes specialty practice, Chicago, IL
GLP-1 and Specialty Medication Authorization
The GLP-1 receptor agonist class — semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), liraglutide — has transformed diabetes and obesity management, but the authorization burden is substantial. Commercial payers require documentation of diabetes diagnosis (or BMI thresholds for obesity indications), prior treatment failures, and specific HbA1c or weight criteria. Step therapy requirements often mandate failed trials of older medications before approving GLP-1s.
A VA manages the GLP-1 authorization workflow: documenting prior treatment history, compiling supporting clinical data, submitting to the appropriate payer channel, and following up on pending authorizations. When step therapy requirements conflict with optimal clinical management, they compile the documentation for step therapy override requests and appeals.
For SGLT2 inhibitors prescribed for diabetes and heart failure or kidney disease, they manage the complex coding and documentation requirements that distinguish cardiorenal indications from straightforward diabetes management — an important distinction for both coverage and appropriate billing.
Lab Coordination and Results Management
Endocrinology patients require regular laboratory monitoring — HbA1c quarterly for poorly controlled diabetes, thyroid function tests every 6–12 months for stable hypothyroidism, lipid panels, kidney function, and annual DEXA scans for osteoporosis management. Coordinating this lab work, ensuring it's completed before follow-up appointments, and managing results communication represents significant administrative volume.
A VA manages lab coordination: generating lab orders for physician review and signature, sending orders to patients with instructions, confirming lab completion before scheduled appointments, and routing results to the appropriate communication pathway. Normal results within target range are communicated through approved protocols; results outside targets are escalated for physician review before communication to patients.
This systematic lab management means endocrinologists arrive at follow-up appointments with complete, current lab data — improving appointment efficiency and clinical decision-making.
Thyroid Disease and Chronic Condition Follow-Up
Endocrinology practices carry large panels of thyroid patients who need periodic monitoring but don't require frequent physician visits. Hypothyroidism managed with stable levothyroxine doses, autoimmune thyroiditis being monitored, and post-thyroid cancer patients on suppression therapy all require systematic follow-up without necessarily needing frequent office visits.
A VA manages recall and follow-up for stable chronic condition patients: sending lab orders for scheduled monitoring, reviewing lab results against target ranges with physician protocols, notifying patients of results and next steps, and scheduling appointments when results suggest medication adjustment. For post-thyroidectomy cancer patients, they coordinate thyroglobulin monitoring, radioiodine scan scheduling, and imaging follow-up per the oncology team's surveillance protocol.
This systematic chronic disease management keeps stable patients engaged in their care, generates the lab-driven touch points that maintain patient relationships, and creates the ongoing revenue from monitoring visits and labs that sustains the practice.
Getting Started with Endocrinology VA Support
Endocrinology VA support runs $12–$22/hour depending on function. Start with CGM and GLP-1 prior authorization management — where the administrative burden is highest and the impact on patient care is most direct. Expand to lab coordination and patient communication as the VA develops familiarity with your practice.
Virtual Assistant VA provides medical administrative VAs with endocrinology practice experience. Contact us to discuss how VA support can reduce your authorization burden.